组织工程模型模拟T细胞介导的口腔黏膜炎症性疾病
本研究构建了含极化T细胞的口腔黏膜等效物以模拟口腔扁平苔藓发病机制。模型显示T细胞向上皮募集伴随CCL5、CXCL9、CXCL10分泌增加及组织损伤,而Jak抑制剂、KCa3.1通道抑制剂或氯倍他索可预防细胞因子释放和组织损伤。
要点
- 组织工程口腔黏膜模型可模拟T细胞介导的口腔炎症性疾病。
- T细胞向上皮募集与CCL5、CXCL9、CXCL10分泌增加相关。
- 氯倍他索及Jak、KCa3.1抑制剂可减轻模型中的组织损伤。
核心结论
- 含极化T细胞的组织工程口腔黏膜等效物可重现口腔扁平苔藓样炎症与组织损伤。
研究设计与样本
- 研究构建了含极化T细胞的口腔黏膜等效物,外周血CD4+和CD8+ T细胞经激活极化为Th1和细胞毒性T细胞。
- 口腔黏膜等效物由口腔角质形成细胞在口腔成纤维细胞填充的水凝胶上培养形成复层鳞状上皮。
主要发现
- 口腔黏膜等效物经IFN-γ和TNF-α或Th1细胞培养基刺激后,炎症细胞因子和趋化因子分泌增加。
- T细胞向 epithelium 募集与T细胞趋化因子CCL5、CXCL9和CXCL10分泌增加相关。
- 组织学评估显示组织损伤与cleaved caspase-3及laminin-5表达改变相关。
关键数值与推荐
- 针对Jak、KCa3.1通道的抑制剂或氯倍他索(溶液及黏膜黏附贴片形式)可预防细胞因子和趋化因子释放及组织损伤。
临床怎么用
- 该疾病模型可用于探究口腔扁平苔藓等T细胞介导口腔黏膜炎症的发病机制。
- 该模型可作为测试新型治疗药物或治疗方式的平台。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T-cell-mediated oral mucocutaneous inflammatory conditions, including oral lichen planus, are common, but development of new treatments aimed at relieving symptoms and controlling oral lichen planus progression is hampered by the lack of experimental models. In this study, we developed a tissue-engineered oral mucosal equivalent containing polarized T-cells to replicate oral lichen planus pathogenesis. Peripheral blood CD4+ and CD8+ T-cells were isolated, activated, and polarized into T helper 1 and cytotoxic T cells. Oral mucosal equivalents were constructed by culturing oral keratinocytes on an oral fibroblast-populated hydrogel to produce a stratified squamous epithelium. Oral mucosal equivalent stimulated with IFN-γ and TNF-α or medium from T helper 1 cells caused increased secretion of inflammatory cytokines and chemokines. A model of T-cell-mediated inflammatory disease was developed by combining oral mucosal equivalent on top of a T helper 1 and cytotoxic T-cell-containing hydrogel, followed by epithelial stimulation with IFN-γ and TNF-α. T-cell recruitment toward the epithelium was associated with increased secretion of T-cell chemoattractants CCL5, CXCL9, and CXCL10. Histological assessment showed tissue damage associated with cleaved caspase-3 and altered laminin-5 expression. Treatment with inhibitors directed against Jak, KCa3.1 channels, or clobetasol in solution and through a mucoadhesive patch prevented cytokine and chemokine release and tissue damage. This disease model has potential to probe for mechanisms of pathogenesis or as a test platform for novel therapeutics or treatment modalities.
引用
- El-Howati A, Edmans JG, Santocildes-Romero ME, et al. A Tissue-Engineered Model of T-Cell-Mediated Oral Mucosal Inflammatory Disease. J Invest Dermatol. 2024. PMID: 39366520. doi:10.1016/j.jid.2024.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。